Year1
- 型号：
- 厄洛替尼片
- 规格：
- 150mg*30片/盒
- 有效期：
- 36个月
)
)English namebr/> )Chinese Pinyinbr/> )
)[Main ingredients]
)The main ingredients of this product are Erlotinib hydrochloride.
)
)
)[Characteristics]
)[India] Tablets are round, biconvex, white coated tablets.
)[Indications]
) Erlotinib can be tried as a third-line treatment for locally advanced or metastatic non-small cell lung cancer that has failed two or more chemotherapy regimens. This indication is based on the results of the aforementioned phase III clinical study abroad. The efficacy of second-line treatment for Chinese non-small cell lung cancer needs to be confirmed by further clinical studies. Two multicenter, placebo-controlled, randomized phase III trials in the first-line treatment of patients with locally advanced or metastatic disease showed that there was no clinical benefit when taking erlotinib concurrently with platinum-based chemotherapy (carboplatin + paclitaxel or gemcitabine + cisplatin). benefit and is therefore not recommended as first-line treatment in these conditions.
)
)【Usage and Dosage】
)The recommended dose of erlotinib alone for non-small cell lung cancer is /day, taken at least one hour before or one hour after eating.
)【Packaging】
) Blister packaging sheet/box
)
)【Storage】
) Store at ℃. ~℃ is also acceptable. Medicines should be kept out of the reach of children.
)
)[Specifications]
)*Pieces/Box
)
)[Validity Period]
) Months
)
)[Approval number]
)Registration certificate number
)National drug approval number
)
)[Manufacturer]
)Company name Shanghai Roche
)India
)Product price (unit yuan)
)No. Drug name and generic name Manufacturer and specifications Price and discount
)
)Erlotinib hydrochloride
) Specifications *Reference price for tablets/box￥yuan
)
WhatsApp
